Diagnostic Value of Anti-MCV in Pts With RA

NCT03265236 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2017-08-29

No results posted yet for this study

Summary

The aim of this work is to evaluate the diagnostic value of anti-MCV antibodies in rheamatoid arthritis patients and to correlate its relationtion disease activity and manifestations.

Conditions

  • Anti-MCV in Rheamatoid Arthritis

Interventions

DIAGNOSTIC_TEST

Anti - modified citrullinate vimentin

patients with early and late RA

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • assiut university · Assiut University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-12-01
Completion
2019-02-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03265236 on ClinicalTrials.gov